Depressed low frequency power of heart rate variability as an independent predictor of sudden death in chronic heart failure.

AIMS Identification of patients with chronic heart failure at risk for sudden death remains difficult. We sought to assess the prognostic value for all-cause and sudden death of time and frequency domain measures of heart rate variability in chronic heart failure. METHODS AND RESULTS We prospectively enrolled 190 patients with chronic heart failure in sinus rhythm, mean age 61+/-12 years, 109 (57.4%) in NYHA class II and 81 (42.6%) in classes III or IV, mean cardiothoracic ratio 57.6+/-6.4% and mean left ventricular ejection fraction 28.2+/-8.8%, 85 (45%) with ischaemic and 105 (55%) with idiopathic dilated cardiomyopathy. Time and frequency domain measures of heart rate variability were obtained from 24 h Holter ECG recordings, spectral measures were averaged for calculation of daytime (1000h-1900h) and night-time (2300h-0600h) values. During follow-up (22+/-18 months), 55 patients died, 21 of them suddenly and two presented with a syncopal spontaneous sustained ventricular tachycardia. In multivariate analysis, independent predictors for all-cause mortality were: ischaemic heart disease, cardiothoracic ratio > or =60% and standard deviation of all normal RR intervals <67 ms (RR = 2.5, 95% CI 1.5-4.2). Independent predictors of sudden death were: ischaemic heart disease and daytime low frequency power <3.3 ln (ms(2)) (RR = 2.8, 95% CI 1.2-8.6). CONCLUSION Depressed heart rate variability has independent prognostic value in patients with chronic heart failure; spectral analysis identifies an increased risk for sudden death in these patients.

[1]  Variabilité de la fréquence cardiaque dans l'insuffisance cardiaque chronique. Influence de la gravité et de l'étiologie. , 1994 .

[2]  M. Creager,et al.  Baroreceptor function in congestive heart failure: effect on neurohumoral activation and regional vascular resistance. , 1987, Circulation.

[3]  K. Swedberg,et al.  Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. , 1990, Circulation.

[4]  G. Parati,et al.  Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation. A critical appraisal. , 1995, Hypertension.

[5]  G. Casolo,et al.  Decreased spontaneous heart rate variability in congestive heart failure. , 1989, The American journal of cardiology.

[6]  M. A. Plant.  Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality , 1991 .

[7]  P. Grayburn,et al.  Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm? , 1997, Journal of the American College of Cardiology.

[8]  N Engl,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. , 1997, Circulation.

[9]  M Pagani,et al.  Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. , 1997, Circulation.

[10]  Australia..  Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease , 1997, The Lancet.

[11]  M G Kienzle,et al.  Clinical, hemodynamic and sympathetic neural correlates of heart rate variability in congestive heart failure. , 1992, The American journal of cardiology.

[12]  G. Breithardt,et al.  Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. , 1996 .

[13]  S. Boveda,et al.  QT interval dispersion as a predictor of arrhythmic events in congestive heart failure. Importance of aetiology. , 1998, European heart journal.

[14]  L. Fauchier,et al.  Heart rate variability in idiopathic dilated cardiomyopathy: characteristics and prognostic value. , 1997, Journal of the American College of Cardiology.

[15]  M. Janse,et al.  Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials , 1997, The Lancet.

[16]  P. Ponikowski,et al.  Circadian pattern of heart rate variability in chronic heart failure patients. Effects of physical training. , 1995, European heart journal.

[17]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[18]  J. Haaksma,et al.  Relation between severity of disease and impairment of heart rate variability parameters in patients with chronic congestive heart failure secondary to coronary artery disease. , 1995, American Journal of Cardiology.

[19]  J. Cohn,et al.  Plasma Norepinephrine, Plasma Renin Activity, and Congestive Heart Failure Relations to Survival and the Effects of Therapy in V‐HeFT II , 1993, Circulation.

[20]  A. Malliani,et al.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use , 1996 .

[21]  A. Camm,et al.  Heart rate variability and its relation to ventricular arrhythmias in congestive heart failure. , 1994, British heart journal.

[22]  J. Le Heuzey,et al.  Effects of bisoprolol on heart rate variability in heart failure. , 1996, The American journal of cardiology.

[23]  P. Sleight,et al.  Physical activity influences heart rate variability and very-low-frequency components in Holter electrocardiograms. , 1996, Cardiovascular research.

[24]  K. Yoshioka,et al.  Alterations of sympathovagal balance in patients with hypertrophic and dilated cardiomyopathies assessed by spectral analysis of RR interval variability. , 1995, European heart journal.

[25]  D J van Veldhuisen,et al.  Prognostic value of heart rate variability in chronic congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. , 1997, The American journal of cardiology.

[26]  N. Montano,et al.  Evidence for a central origin of the low-frequency oscillation in RR-interval variability. , 1998, Circulation.

[27]  S Capewell,et al.  Decreased cardiac parasympathetic activity in chronic heart failure and its relation to left ventricular function. , 1992, British heart journal.

[28]  G. PORENTA,et al.  Prognostic Value of Heart Rate Variability in Patients Awaiting Cardiac Transplantation , 1992, Pacing and clinical electrophysiology : PACE.

[29]  S. Cerutti,et al.  Can power spectral analysis of heart rate variability identify a high risk subgroup of congestive heart failure patients with excessive sympathetic activation? A pilot study before and after heart transplantation. , 1994, British heart journal.

[30]  E. J. Brown,et al.  The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.

[31]  F Boomsma,et al.  Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure. The Dutch Ibopamine Multicenter Trial Study Group. , 1996, Journal of the American College of Cardiology.

[32]  Bertram Pitt,et al.  Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) , 1997, The Lancet.

[33]  R. Prescott,et al.  Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). , 1998, Circulation.

[34]  D. Levy,et al.  The epidemiology of heart failure: the Framingham Study. , 1993, Journal of the American College of Cardiology.

[35]  P. Ponikowski,et al.  Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 1997, The American journal of cardiology.

[36]  P. Binkley,et al.  Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. , 1991, Journal of the American College of Cardiology.

[37]  G D Pinna,et al.  Abnormal awake respiratory patterns are common in chronic heart failure and may prevent evaluation of autonomic tone by measures of heart rate variability. , 1997, Circulation.

[38]  R J Cohen,et al.  Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis. , 1988, The American journal of cardiology.

[39]  A. Moss,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.

[40]  J. Fleiss,et al.  Frequency Domain Measures of Heart Period Variability and Mortality After Myocardial Infarction , 1992, Circulation.

[41]  H. Crijns,et al.  Heart rate variability in left ventricular dysfunction and heart failure: effects and implications of drug treatment. , 1994, British heart journal.